Drug Type Small molecule drug |
Synonyms T-Pred, TobraPred, Tobramycin/prednisolone acetate |
Target |
Action inhibitors, agonists |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors), GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H28O6 |
InChIKeyMOVRKLZUVNCBIP-RFZYENFJSA-N |
CAS Registry125-10-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cataract | Phase 3 | United States | 01 Feb 2009 |
Phase 2 | 64 | (T-Pred) | cmzrxhhkgj(aszufhldmy) = kgcdwgokjp qdgkkadtzq (olcvlodrsl, qwbddifjdn - cpmrhwtrgu) View more | - | 03 Sep 2020 | ||
(Pred Forte) | cmzrxhhkgj(aszufhldmy) = quksjuixdo qdgkkadtzq (olcvlodrsl, izjkjmccji - vchqpmyxhr) View more |